Neoplasia/BPH

	Association between oxidative balance score and benign prostatic hyperplasia: an analysis based on the NHANES from 2003 to 2008. Aging Male Xie F, Yang Z. PMID: 41510672 [PubMed - indexed for MEDLINE]
	The Role of Selenium as an Antioxidant in the Treatment of Renal Cell Carcinoma. Cureus El Menawy Z, Hmoud H, Taher M, Atef T, Elsharkawi I, Ranade AV. PMID: 41510455 [PubMed]
	Predictive impact of PI-RADS 3 lesion volume/total prostate volume ratio in prostate cancer diagnosis in biopsy-naÃ¯ve patients. Turk J Med Sci Özsoy E, Kutluhan MA, Tokuç E, Kayar R, Demir S, Meriç K, Öztürk M. PMID: 41509953 [PubMed - indexed for MEDLINE]
	Assessing the efficiency of methods to teach adolescents about testicular cancer and testicular self-examination. Turk J Med Sci Gül Güven A, Jafari L, Günel MD, Akbulut Ö. PMID: 41509935 [PubMed - indexed for MEDLINE]
	Testicular cancer in intersex individuals: A systematic review for clinical practice. Int J Cancer Jones NC, Madhavaram A, Haver MK, Quinn GP. PMID: 41508675 [PubMed - as supplied by publisher]
	Pretreatment predictive factors for primary resistance to nivolumab plus ipilimumab in advanced renal cell carcinoma: a multicenter collaborative study. Jpn J Clin Oncol Masui K, Hayata N, Yamasaki T, Yamaguchi T, Kanno T, Ito N, Yoshimura K, Masui S, Segawa T, Kanamaru S, Okumura K, Onishi H, Shichiri Y, Ishitoya S, Sumiyoshi T, Kita Y, Goto T, Kobayashi T, Sawada A. PMID: 41508296 [PubMed - as supplied by publisher]
	Clinical validation of UroCAD test for upper tract urothelial carcinoma detection: results from a prospective multi-center study. J Hematol Oncol Yang G, Zeng S, He W, Zhang L, Xu C, Pan J, Xue W. PMID: 41508041 [PubMed - indexed for MEDLINE]
	Modeling primary immunotherapy resistance in metastatic bladder cancer: a syngeneic, bioluminescent mouse model. Cancer Cell Int Xu D, Jacob JJ, Wieczorek K, Wang L, Yu H, Wang J, Xu B, Hussein AA, Guru K, Goodrich DW, Li Q. PMID: 41507921 [PubMed - as supplied by publisher]
	Immunotherapy combinations in favourable risk score metastatic renal cell carcinoma, an individual patients data metanalysis. BMC Cancer Di Civita MA, Marinelli D, Michetti VM, Artemi A, Ballario A, Torchia A, Pappalardo L, Pecoraro M, Speranza I, Sciarra A, Panebianco V, Roberto M, Santini D. PMID: 41507833 [PubMed - as supplied by publisher]
	Burden of prostate cancer in older adults, 1990-2021: a systematic analysis based on the global burden of disease study 2021. BMC Geriatr Ding W, Li L, Wang ZL, Liu YQ, Wang JW, Tao LS. PMID: 41507812 [PubMed - as supplied by publisher]
	Zonal origin combined with IVIM parameters could predict ISUP risk groups of prostate cancer. Br J Radiol Zhong J, Che Z, Qin X, Zhang Y, Yang Q, Ding J. PMID: 41507079 [PubMed - as supplied by publisher]
	Effects of Causal and Noncausal Components of Screening on Prostate Cancer Mortality: A Mediation Analysis from the Dutch, Finnish, and Swedish Centers of the European Randomized Study of Screening for Prostate Cancer. Eur Urol Oncol Remmers S, Talala K, Roobol MJ, Hugosson J, Arnsrud Godtman R, Nieboer D, Auvinen A, ERSPC Rotterdam, Sweden, and Finland study groups. PMID: 41507018 [PubMed - as supplied by publisher]
	Feasibility of Recruitment, Perceived Genetic Risk and Susceptibility Beliefs, and Saliva Sample Collection in a Community-Based Prostate Cancer Genetic Risk Pilot Study. Am J Mens Health Boxtha C, El-Kolalli S, Denis J, O'Neil A, Vadaparampil ST, Abdulla R, Park H, Park JY, Gwede CK. PMID: 41506624 [PubMed - indexed for MEDLINE]
	Long-Term Outcomes of Prostate Cancer Patients with Metastases in the Anterior Fat Pad and Pelvic Lymph Nodes: Nodal Upstaging Without Worse Long-Term Outcomes. Hum Pathol Yu B, Zhou X, Bian F, Yan F, Franz F. PMID: 41506607 [PubMed - as supplied by publisher]
	A Comparison of ablation therapy and partial nephrectomy for the Treatment of Renal Cell Carcinoma: A Systematic Review and Meta-analysis. Urol Int Deng R, Li Y, Zhang Z. PMID: 41505378 [PubMed - as supplied by publisher]
	Machine Learning Integration Framework Constructs a Lactylation-Associated Gene Signature to Improve Prognosis in Bladder Cancer. Cancer Med Wang J, Lu Q, Jiao P, Jian J, Zheng Q, Chen Z, Liu X, Wan S, Wang L. PMID: 41505248 [PubMed - indexed for MEDLINE]
	Study on the Role of Long Non-Coding RNA GAS5 in Promoting the Malignant Progression of Prostate Cancer by Regulating miR-12/GPRC5B Signaling Axis. Bull Exp Biol Med Li C. PMID: 41505048 [PubMed - as supplied by publisher]
	Non-invasive urine-based detection of PSMA-positive exosomes using a dual-aptamer electrochemical aptasensor for prostate cancer diagnosis. Mikrochim Acta Amin-Sadrabadi E, Omidfar K. PMID: 41505006 [PubMed - in process]
	Significance and Implications of Prostate Cancer: Critical Overview for Future Directions in Africa. Cancer Invest Gayi BK, Aiduenu AF, Dofuor AK, Tawiah-Nyarko S, Loh SK, Yamoah JAA, Ekloh W, Akomea A, Anovunga SA, Asafu-Adjaye A. PMID: 41504175 [PubMed - as supplied by publisher]
	Influence of androgen deprivation therapy on physical performance and muscle strength in prostate cancer patients - a systematic review. Rep Pract Oncol Radiother Szarzy, Barczak I, Giermek K, Garczyk A, Mardas M, Stelmach-Mardas M. PMID: 41503555 [PubMed]

Articles 1 - 20 / 184535

Page 1 of 9227



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy